Bausch & Lomb (BLCO) Current Assets (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Current Assets came in at $2.9 billion in Q2 2026, up 2.67% YoY from $2.8 billion in Q2 2025, and up 5.26% on a QoQ basis from $2.8 billion in Q1 2026.
Bausch & Lomb (BLCO) Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Current Assets data on file, last reported at $2.9 billion in Q2 2026.
- Quarterly Current Assets rose 2.67% year-over-year to $2.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.9 billion (up 2.67% YoY) and the FY2025 annual result came in at $3.0 billion, up 6.78% from the prior year.
- Current Assets advanced to $2.9 billion in Q2 2026, from $2.8 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $3.0 billion in Q4 2025 to a low of $1.7 billion in Q1 2022.
- A 5-year average of $2.5 billion and a median of $2.7 billion in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets surged 32.54% — and 2025, when it slipped 1.79%.
- Tracing BLCO's Current Assets over 5 years: stood at $2.1 billion in 2022, then gained by 28.31% to $2.7 billion in 2023, then climbed by 1.68% to $2.8 billion in 2024, then climbed by 6.78% to $3.0 billion in 2025, then fell by 1.85% to $2.9 billion in 2026.
- The last three Current Assets figures came in at $2.9 billion (Q2 2026), $2.8 billion (Q1 2026), and $3.0 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Bausch & Lomb | 6.16 Bn | 5.78 Bn | 867.00 Mn | 2.92 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.92 Bn |
| Mar 31, 2026 | 2.78 Bn |
| Dec 31, 2025 | 2.98 Bn |
| Sep 30, 2025 | 2.86 Bn |
| Jun 30, 2025 | 2.85 Bn |
| Mar 31, 2025 | 2.69 Bn |
| Dec 31, 2024 | 2.79 Bn |
| Sep 30, 2024 | 2.83 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 2.74 Bn |
| Dec 31, 2023 | 2.74 Bn |
| Sep 30, 2023 | 2.46 Bn |
| Jun 30, 2023 | 2.32 Bn |
| Mar 31, 2023 | 2.18 Bn |
| Dec 31, 2022 | 2.14 Bn |
| Sep 30, 2022 | 1.86 Bn |
| Jun 30, 2022 | 2.00 Bn |
| Mar 31, 2022 | 1.72 Bn |
| Dec 31, 2021 | 1.64 Bn |